Drug Profile


Alternative Names: Ac-Din; Acetyldinaline; CI 994; GOE 5549; PD 123654; PD 130636

Latest Information Update: 06 Mar 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Goedecke; Pfizer
  • Developer Pfizer
  • Class Aniline compounds; Antineoplastics
  • Mechanism of Action Angiogenesis inhibitors; Histone deacetylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Breast cancer; Colorectal cancer; Lung cancer; Pancreatic cancer

Most Recent Events

  • 06 Mar 2008 Discontinued - Phase-I for Colorectal cancer in USA (PO)
  • 06 Mar 2008 Discontinued - Phase-II for Breast cancer in USA (PO)
  • 06 Mar 2008 Discontinued - Phase-II for Lung cancer in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top